Topical 5‐aminolaevulinic acid photodynamic therapy for the treatment of skin conditions other than non‐melanoma skin cancer

Summary  Topical 5‐aminolaevulinic acid (ALA) photodynamic therapy (PDT) is used increasingly for superficial non‐melanoma skin cancer (NMSC) and dysplasia. However, the relative accumulation of the photosensitizer protoporphyrin IX (PpIX) in diseased tissue is not specific for neoplastic disease, and has been shown after the application of ALA to benign proliferative skin conditions such as viral warts and psoriasis. This review appraises the quality of evidence available for the use of topical ALA–PDT in the treatment of skin conditions other than NMSC. The diseases that have been studied in most detail are recalcitrant viral warts, acne, psoriasis and cutaneous T‐cell lymphoma. Publications relating to the treatment of other diseases by topical PDT are restricted to small case series or case reports. The relevant literature will be discussed and the potential for topical PDT in the treatment of several skin diseases is highlighted, although more detailed studies are required to clarify the role of PDT beyond the treatment of NMSC.

[1]  Christian Gluud,et al.  Photodynamic therapy with 5-aminolaevulinic acid or placebo for recalcitrant foot and hand warts: randomised double-blind trial , 2000, The Lancet.

[2]  H. Kerl,et al.  Photodynamic therapy for mycosis fungoides after topical photosensitization with 5-aminolevulinic acid. , 1994, Journal of the American Academy of Dermatology.

[3]  H. Wulf,et al.  Photodynamic therapy with 5‐aminolevulinic acid in the treatment of actinic cheilitis , 1996, The British journal of dermatology.

[4]  H. Lui,et al.  Topical photodynamic therapy with 5‐aminolaevulinic acid does not induce hair regrowth in patients with extensive alopecia areata , 2000, The British journal of dermatology.

[5]  R. Anderson,et al.  Topical ALA-photodynamic therapy for the treatment of acne vulgaris. , 2000, The Journal of investigative dermatology.

[6]  M. Fehr,et al.  Photodynamic therapy of vulvar intraepithelial neoplasia III using topically applied 5-aminolevulinic acid. , 2001, Gynecologic oncology.

[7]  I. Stender,et al.  Recalcitrant hand and foot warts successfully treated with photodynamic therapy with topical 5‐aminolaevulinic acid: a pilot study , 1999, Clinical and experimental dermatology.

[8]  N. Kollias,et al.  Selectivity of protoporphyrin IX fluorescence for condylomata after topical application of 5‐aminolaevulinic acid: implications for photodynamic treatment , 1997, The British journal of dermatology.

[9]  A. Anstey,et al.  Erythroplasia of Queyrat treated by topical aminolaevulinic acid photodynamic therapy: a cautionary tale , 2000, The British journal of dermatology.

[10]  T. Hunziker,et al.  Photodynamic therapy for mycosis fungoides after topical photosensitization with 5-aminolevulinic acid. , 1995, Journal of the American Academy of Dermatology.

[11]  R. Stadler,et al.  Photodynamische Therapie kutaner T-Zell-Lymphome in besonderer Lokalisation , 1999, Der Hautarzt.

[12]  C. Whitehurst,et al.  Photodynamic treatment for lower genital tract intraepithelial neoplasia , 1998, The Lancet.

[13]  P. Collins,et al.  Topical 5‐aminolaevulinic acid photodynamic therapy for tumour‐stage mycosis fungoides , 2001, The British journal of dermatology.

[14]  L. Braathen,et al.  Topical photodynamic therapy in verrucae. A pilot study. , 1995, Dermatology.

[15]  M Landthaler,et al.  Topical photodynamic therapy for localized scleroderma. , 2000, Acta dermato-venereologica.

[16]  K. König,et al.  Photodynamic therapy in psoriasis: suppression of cytokine production in vitro and recording of fluorescence modification during treatment in vivo , 2004, Archives of Dermatological Research.

[17]  T. Mang,et al.  Photodynamic therapy in the management of neoplasms of the perianal skin. , 1992, Archives of surgery.

[18]  P. Calzavara-Pinton,et al.  Repetitive photodynamic therapy with topical delta-aminolaevulinic acid as an appropriate approach to the routine treatment of superficial non-melanoma skin tumours. , 1995, Journal of photochemistry and photobiology. B, Biology.

[19]  Q. Peng,et al.  5‐Aminolevulinic Acid‐Based Photodynamic Therapy: Principles and Experimental Research , 1997, Photochemistry and photobiology.

[20]  M. E. Kenney,et al.  Treatment of Malignant Melanoma by High‐Peak‐Power 1064 nm Irradiation Followed by Photodynamic Therapy , 1998, Photochemistry and photobiology.

[21]  K Svanberg,et al.  Photodynamic therapy of non‐melanoma malignant tumours of the skin using topical δ‐amino levulinic acid sensitization and laser irradiation , 1994, The British journal of dermatology.

[22]  M. Berns,et al.  Response of psoriasis to red laser light (630 nm) following systemic injection of hematoporphyrin derivative , 1984, Lasers in surgery and medicine.

[23]  I. Stender,et al.  Treatment of recalcitrant verrucae by photodynamic therapy with topical application of δ‐aminolaevulinic acid , 1996, Clinical and experimental dermatology.

[24]  T. Foster,et al.  Effectiveness of delta-aminolevulinic acid-induced protoporphyrin as a photosensitizer for photodynamic therapy in vivo. , 1995, Cancer research.

[25]  Z. Malik,et al.  Photodynamic therapy of cutaneous lymphoma using 5-aminolevulinic acid topical application. , 2000, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[26]  A. Batlle,et al.  Topical and intratumoral photodynamic therapy with 5-aminolevulinic acid in a subcutaneous murine mammary adenocarcinoma. , 1999, Cancer letters.

[27]  M W Berns,et al.  Selective photosensitizer distribution in vulvar condyloma acuminatum after topical application of 5-aminolevulinic acid. , 1996, American journal of obstetrics and gynecology.

[28]  N. Oleinick,et al.  LARGE MUTAGENIC LESIONS ARE INDUCED BY PHOTODYNAMIC THERAPY IN MURINE L5178Y LYMPHOBLASTS * , 1993, Photochemistry and photobiology.

[29]  A. Porwit,et al.  Photodynamic therapy with topical 5-aminolevulinic acid for mycosis fungoides: clinical and histological response. , 2001, Acta dermato-venereologica.

[30]  Z. Malik,et al.  Inactivation of erythrocytic, lymphocytic and myelocytic leukemic cells by photoexcitation of endogenous porphyrins. , 1989, Journal of photochemistry and photobiology. B, Biology.

[31]  M. Delfino,et al.  Topical hematoporphyrin plus UVA for treatment of alopecia areata. , 1987, Photo-dermatology.

[32]  W. Boehncke,et al.  Systemic photodynamic therapy is a safe and effective treatment for psoriasis. , 2000, Archives of dermatology.

[33]  H. Wulf,et al.  Photodynamic therapy of recalcitrant warts with 5-aminolevulinic acid: a retrospective analysis. , 1999, Acta dermato-venereologica.

[34]  M. Stringer,et al.  The variable response of plaque psoriasis after a single treatment with topical 5‐aminolaevulinic acid photodynamic therapy , 1997, The British journal of dermatology.

[35]  S. Tajima,et al.  Photodynamic therapy for acne vulgaris with topical 5-aminolevulinic acid. , 2000, Archives of dermatology.

[36]  G. Kuhnle,et al.  In vivo kinetics and spectra of 5-aminolaevulinic acid-induced fluorescence in an amelanotic melanoma of the hamster. , 1994, British Journal of Cancer.

[37]  Ninomiya,et al.  Photodynamic therapy for inoperable vulval Paget's disease using δ‐aminolaevulinic acid: successful management of a large skin lesion , 1999, The British journal of dermatology.

[38]  A. Oseroff,et al.  THE ROLE OF TRANSFERRIN RECEPTOR (CD71) IN PHOTODYNAMIC THERAPY OF ACTIVATED AND MALIGNANT LYMPHOCYTES USING THE HEME PRECURSOR δ‐AMINOLEVULINIC ACID (ALA) , 1995, Photochemistry and photobiology.

[39]  W. Diezel,et al.  [Anti-psoriasis and phototoxic effect of a hematoporphyrin derivative following topical administration and irradiation with visible light]. , 1989, Dermatologische Monatschrift.

[40]  A. Johnsson,et al.  AN ACTION SPECTRUM FOR BLUE AND NEAR ULTRAVIOLET IN ACTIVATION OF Propionibacterium acnes; WITH EMPHASIS ON A POSSIBLE PORPHYRIN PHOTOSENSITIZATION , 1986, Photochemistry and photobiology.

[41]  W. Sterry,et al.  Treatment of psoriasis by topical photodynamic therapy with polychromatic light , 1994, The Lancet.

[42]  W. Cunliffe,et al.  Phototherapy and acne vulgaris , 2000, The British journal of dermatology.

[43]  H Kerl,et al.  Topical photodynamic therapy with endogenous porphyrins after application of 5-aminolevulinic acid. An alternative treatment modality for solar keratoses, superficial squamous cell carcinomas, and basal cell carcinomas? , 1993, Journal of the American Academy of Dermatology.

[44]  W. Stahl,et al.  Porphyrins Preferentially Accumulate in a Melanoma Following Intravenous Injection of 5-Aminolevulinic Acid , 1997, Biological chemistry.

[45]  A. Porwit,et al.  Topical 5-aminolevulinic acid-based photodynamic therapy for mycosis fungoides - A study of cell proliferation and apoptosis before and after therapy , 1998 .

[46]  W. Stolz,et al.  Epidermodysplasia verruciformis treated using topical 5‐aminolaevulinic acid photodynamic therapy , 1999, The British journal of dermatology.

[47]  J H McColl,et al.  Photodynamic therapy for basal cell carcinoma: effect of tumor thickness and duration of photosensitizer application on response. , 1998, Archives of dermatology.

[48]  J C Kennedy,et al.  Phototoxic damage to sebaceous glands and hair follicles of mice after systemic administration of 5-aminolevulinic acid correlates with localized protoporphyrin IX fluorescence. , 1990, The American journal of pathology.

[49]  S. Mashiko,et al.  Singlet Oxygen (1Δg) Generation from Coproporphyrin inPropionibacterium acneson Irradiation , 1996 .

[50]  G. Fabbrocini,et al.  Photodynamic therapy with topical δ-aminolaevulinic acid for the treatment of plantar warts , 2001 .

[51]  P. Papageorgiou,et al.  Phototherapy with blue (415 nm) and red (660 nm) light in the treatment of acne vulgaris , 2000, The British journal of dermatology.

[52]  H Stepp,et al.  Photodynamic therapy of vulvar intraepithelial neoplasia using 5‐aminolevulinic acid , 2000, International journal of cancer.

[53]  T. Mang,et al.  An evaluation of photodynamic therapy in the management of cutaneous metastases of breast cancer. , 1993, European journal of cancer.

[54]  W. Boehncke,et al.  Comparison of sensitivity towards photodynamic therapy of cutaneous resident and infiltrating cell types in vitro , 1996, Lasers in surgery and medicine.

[55]  Peter J. Dwyer,et al.  Photodynamic Therapy for Nevus Sebaceus With Topical δ-Aminolevulinic Acid , 1999 .

[56]  K Svanberg,et al.  Photodynamic therapy utilising topical delta-aminolevulinic acid in non-melanoma skin malignancies of the eyelid and the periocular skin. , 1999, Acta ophthalmologica Scandinavica.

[57]  D. V. Ash,et al.  Superficial photodynamic therapy with topical 5-aminolaevulinic acid for superficial primary and secondary skin cancer. , 1994, British Journal of Cancer.

[58]  Robinson,et al.  Erythroplasia of Queyrat treated by topical aminolaevulinic acid photodynamic therapy , 1999, The British journal of dermatology.

[59]  S. Tajima,et al.  Photodynamic therapy of acne vulgaris with topical δ‐aminolaevulinic acid and incoherent light in Japanese patients , 2001, The British journal of dermatology.

[60]  M Korell,et al.  Photodynamic therapy of vulvar lichen sclerosus with 5-aminolevulinic acid. , 1999, Obstetrics and gynecology.

[61]  G. Stables,et al.  The accumulation of protoporphyrin IX in plaque psoriasis after topical application of 5-aminolevulinic acid indicates a potential for superficial photodynamic therapy. , 1996, The Journal of investigative dermatology.

[62]  H. Klamová,et al.  Selective destruction of leukaemic cells by photo-activation of 5-aminolaevulinic acid-induced protoporphyrin-IX. , 1998, Journal of photochemistry and photobiology. B, Biology.

[63]  T. Dougherty,et al.  Photodynamic therapy for residual neoplasms of the perianal skin , 2000, Diseases of the colon and rectum.

[64]  H. Eich,et al.  [Photodynamic therapy of cutaneous T-cell lymphoma at special sites]. , 1999, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.

[65]  R. G. Frank,et al.  Photodynamic therapy for condylomata acuminata with local application of 5-aminolevulinic acid. , 1996, Genitourinary medicine.

[66]  CLAUDE C. FRAZIER,et al.  PHOTODYNAMIC THERAPY IN DERMATOLOGY , 1996, International journal of dermatology.

[67]  J. D. Zollo,et al.  The Roswell Park Cancer Institute experience with extramammary Paget’s disease , 2000, The British journal of dermatology.

[68]  R. Barlow,et al.  Single‐episode photodynamic therapy and vulval intraepithelial neoplasia type III resistant to conventional therapy , 2000, The British journal of dermatology.

[69]  M. Mihm,et al.  Photodynamic Therapy for Nevus Sebaceus With Topical δ-Aminolevulinic Acid , 1999 .

[70]  P Lehmann,et al.  Optimum porphyrin accumulation in epithelial skin tumours and psoriatic lesions after topical application of δ-aminolaevulinic acid , 1999, British Journal of Cancer.

[71]  Kirby,et al.  Treatment of lichen planus of the penis with photodynamic therapy , 1999, The British journal of dermatology.

[72]  A. Goetz,et al.  Photodynamic therapy with 5-aminolaevulinic acid-induced porphyrins of an amelanotic melanoma in vivo. , 1997, Journal of photochemistry and photobiology. B, Biology.

[73]  M. Jirsa,et al.  Photodynamic therapy of cutaneous metastases of breast cancer after local application of meso-tetra-(para-sulphophenyl)-porphin (TPPS4). , 1996, Journal of photochemistry and photobiology. B, Biology.

[74]  G. Stables,et al.  Improved response of plaque psoriasis after multiple treatments with topical 5-aminolaevulinic acid photodynamic therapy. , 1999, Acta dermato-venereologica.

[75]  S. Mashiko,et al.  Singlet oxygen (1 delta g) generation from coproporphyrin in Propionibacterium acnes on irradiation. , 1996, Biochemical and Biophysical Research Communications - BBRC.

[76]  W. Star,et al.  In vivo fluorescence kinetics and photodynamic therapy using 5-aminolaevulinic acid-induced porphyrin: increased damage after multiple irradiations. , 1994, British Journal of Cancer.

[77]  J C Kennedy,et al.  Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. , 1992, Journal of photochemistry and photobiology. B, Biology.

[78]  J. Kennedy,et al.  Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. , 1990, Journal of photochemistry and photobiology. B, Biology.

[79]  C. Whitehurst,et al.  Comparison of photodynamic therapy with cryotherapy in the treatment of Bowen's disease , 1996, The British journal of dermatology.

[80]  G Corbitt,et al.  Immunological and viral factors associated with the response of vulval intraepithelial neoplasia to photodynamic therapy. , 2001, Cancer research.

[81]  W. Lee,et al.  Comparative studies of porphyrin production in Propionibacterium acnes and Propionibacterium granulosum , 1978, Journal of bacteriology.

[82]  A. Knulst,et al.  Phototherapy of acne vulgaris with visible light. , 1997, Dermatology.

[83]  H. Meffert,et al.  [Photodynamic therapy of psoriasis palmaris et plantaris using a topically applied hematoporphyrin derivative and visible light]. , 1989, Dermatologische Monatschrift.